Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress

Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS ...
UroToday

ESMO 2025: KEYNOTE-905 Study Discussion - Perioperative EV + Pembro in Participants with MIBC Who Are Cisplatin-Ineligible

A New Era in the Treatment of Muscle Invasive Bladder Cancer. Discussant of LBA2 - Perioperative (Periop) Enfortumab Vedotin ...
Barron's

Saab AB Series B

Saab AB engages in the production and sale of products, services, and solutions for military defense, commercial aviation and civil security. It operates through the following segments: Aeronautics, ...
Barron's

Svolder AB Series B

Svolder AB engages in investing in listed small and medium-sized enterprises. Its portfolio includes energy, manufacturing, services, retail, information technology, finance, and telecommunications ...